Advertisement

Topics

MiNA Therapeutics Company Profile

15:38 EDT 23rd June 2018 | BioPortfolio

MiNA Therapeutics is a biopharmaceutical company pioneering the discovery and development of a new class of medicines that selectively up-regulate proteins inside patient cells. MiNA’s proprietary RNA activation (RNAa) technology platform enables up-regulation of beneficial proteins by the selective and long lasting transcriptional activation of a target gene. RNAa has unique potential to target diseases that are untreatable with today’s conventional medicine. MiNA’s novel drugs, termed small activating RNAs (saRNAs), leverage existing RNA delivery technologies to accelerate the development of drug candidates. The company is developing MTL-CEBPA, a first in class treatment for advanced liver cancer. MiNA was founded in 2008 by pioneering researchers John Rossi, Nagy Habib and Pal Saetrom. The company is privately held and located in London, United Kingdom. To learn more visit www.minatx.com.


News Articles [793 Associated News Articles listed on BioPortfolio]

Turkish private jet carrying 11 crashes in Iran

Turkish and Iranian officials said there were eight passengers and three crew aboard the plane which crashed in the south of Iran while flying from Sharjah to Istanbul. Media reports in Turkey said t...

MiNA Therapeutics Announces Publication of Pre-Clinical Data Supporting Therapeutic Potential of Clinical Candidate MTL-CEBPA in Liver Cancer and Liver Disease

--Data Published in Oncogene Demonstrate Improvement of Liver Function and Increased Survival in Multiple Disease Models-- MiNA Therapeutics, the pioneer in RNA activation the...

MiNA reports preliminary Phase I data for liver cancer candidate

Mina Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13032018] Prices from USD $250

SummaryMina Therapeutics Ltd Mina Therapeutics, a subsidiary of MiNA Holdings Ltd is a developer of small activating ribonucleic acid therapeutics that selectively upregulate therapeutic proteins. The...

Pan American Silver reduce ciertas actividades en la mina Dolores

"Nuestra prioridad es la protección y seguridad de nuestro personal. Hemos estado supervisando la situación, y en vista de los recientes incidentes que han ocurrido Read more...

What You Need to Know About Indalo Therapeutics

Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.

ADHD in childhood - diagnosis

Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attra...

ADHD in childhood - treatment

Attention deficit hyperactivity disorder, or ADHD, presents with persistent symptoms of inattention, hyperactivity, and impulsivity causing impairment in multiple settings. It is a disorder that attra...

PubMed Articles [435 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia): Baseline characteristics of the study participants.

Type 2 diabetes (T2D) imposes a heavy public health burden in both developed and developing countries. It is necessary to understand the effect of T2D in different settings and population groups. This...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [147 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1237 Associated Companies listed on BioPortfolio]

MiNA Therapeutics

MiNA Therapeutics is a biopharmaceutical company pioneering the discovery and development of a new class of medicines that selectively up-regulate proteins inside patient cells. M...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...

More Information about "MiNA Therapeutics" on BioPortfolio

We have published hundreds of MiNA Therapeutics news stories on BioPortfolio along with dozens of MiNA Therapeutics Clinical Trials and PubMed Articles about MiNA Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MiNA Therapeutics Companies in our database. You can also find out about relevant MiNA Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record